GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/IBD/ultraprocessed grains and IBD
82

ultraprocessed grains and IBD

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated December 1, 2025

The relationship between ultraprocessed grains and inflammatory bowel disease (IBD) has been examined in the context of the Prospective Urban Rural Epidemiology (PURE) study. This study highlights a significant association between the consumption of ultraprocessed grains and an increased risk of developing IBD, which includes conditions such as Crohn's disease and ulcerative colitis. Below is a detailed explanation based on the findings:

What Are Ultraprocessed Grains?

Ultraprocessed grains are a category of foods that undergo extensive refining processes. These processes often remove beneficial nutrients, such as fiber, and incorporate additives like preservatives, flavor enhancers, and texturizers to improve shelf life, taste, and texture. Examples include white bread, certain breakfast cereals, instant noodles, and other refined grain products commonly found in Western diets.

The PURE Study Findings

The PURE study evaluated dietary habits across diverse populations using long-term, multinational cohort data. Key findings include:

  1. Increased Risk of IBD: Higher consumption of ultraprocessed grains was associated with a greater risk of developing IBD. This relationship remained significant even after adjusting for major lifestyle and demographic factors.

  2. Protective Effect of Less Processed Grains: In contrast, consuming less processed grain staples, such as fresh bread and rice, was linked to a reduced risk of IBD.

  3. Broader Implications for Ultraprocessed Foods: The study also observed that diets high in overall ultraprocessed foods, not just grains, were associated with negative impacts on intestinal health, further emphasizing the role of food processing levels.

Mechanisms Linking Ultraprocessed Grains to IBD

The study suggests several mechanisms through which ultraprocessed grains may contribute to intestinal inflammation and increase IBD risk:

  1. Altered Gut Microbiota: Ultraprocessed grains may disrupt the gut microbiome, leading to imbalances that promote inflammation.

  2. Reduced Fiber Intake: The refining process removes dietary fiber, which is essential for maintaining gut health and reducing inflammation.

  3. Exposure to Food Additives: Additives in ultraprocessed grains, such as emulsifiers and artificial flavors, may irritate the intestinal lining, exacerbate inflammation, or negatively affect gut bacteria.

Recommendations

The study's authors recommend minimizing the consumption of ultraprocessed grains as part of a healthy dietary pattern to reduce the risk of IBD. Instead, individuals are encouraged to prioritize less processed grain options and whole foods that retain their natural fiber and nutrient content. Additionally, further research is suggested to pinpoint the specific components of ultraprocessed grains responsible for the increased risk of IBD.

Conclusion

Ultraprocessed grains are linked to a heightened risk of developing IBD due to their potential to disrupt gut health through mechanisms such as microbiota alterations, reduced fiber levels, and exposure to additives. Adopting a diet that emphasizes whole, minimally processed grains can play a protective role against IBD and improve overall intestinal health.

Related Q&A

83

Global evolution of inflammatory bowel disease across epidemiologic stages

The global evolution of inflammatory bowel disease (IBD) can be understood through its progression across four distinct epidemiologic stages, which reflect the changing patterns of incidence, prevalence, and...

84

Diagnostic performance of intestinal ultrasound compared with CT enterography in Crohn’s disease: single-center experience

The study conducted a retrospective single-center analysis to evaluate the diagnostic performance of transabdominal bowel ultrasonography (TBUS) compared with computed tomography enterography (CTE) in identifying intestinal lesions and...

85

Efficacy and safety of IL-23 inhibitors in the treatment of moderate to severe UC

The meta-analysis conducted on randomized controlled trials provides comprehensive insights into the efficacy and safety of IL-23 inhibitors for the treatment of moderate to severe ulcerative colitis (UC)....

86

Upadacitinib in a real-world data from UK

The real-world data on the use of upadacitinib for Crohn’s disease (CD) in the UK provides valuable insights into its effectiveness and safety in a challenging, clinically refractory...

87

single-wavelength endoscopy technology in UC

Single-wavelength endoscopy (SWE) is an advanced imaging technology that uses light of a specific wavelength to enhance visualization of tissue characteristics during endoscopic procedures. In the context of...

88

ESD for high-risk colorectal colitis-associated neoplasia in IBD

Endoscopic submucosal dissection (ESD) has emerged as a highly effective and safe treatment for high-risk colorectal colitis-associated neoplasia (HR-CAN) in patients with inflammatory bowel disease (IBD), according to...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer